Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method

Diagn Microbiol Infect Dis. 2004 Mar;48(3):207-10. doi: 10.1016/j.diagmicrobio.2003.10.004.

Abstract

The minimal inhibitory concentrations of tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin and azithromycin for 28 Singapore clinical Mycoplasma hominis strains were studied using the Etest method. Different incubation conditions did not affect susceptibility categories, except for tetracycline intermediate-susceptibility strains. Tetracycline-susceptibility was only 35.7%. All strains were susceptible to the fluoroquinolones and clindamycin but resistant to azithromycin.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Aza Compounds / pharmacology
  • Azithromycin / pharmacology
  • Ciprofloxacin / pharmacology
  • Clindamycin / pharmacology
  • Drug Resistance, Multiple, Bacterial*
  • Fluoroquinolones / pharmacology*
  • Gatifloxacin
  • Humans
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Mycoplasma hominis / classification
  • Mycoplasma hominis / drug effects*
  • Quinolines / pharmacology
  • Sampling Studies
  • Sensitivity and Specificity
  • Singapore
  • Tetracycline / pharmacology

Substances

  • Anti-Bacterial Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Clindamycin
  • Ciprofloxacin
  • Azithromycin
  • Tetracycline
  • Gatifloxacin
  • Moxifloxacin